Body and Mind Narrows Loss By 30% YoY In Q3, Doubles Down On Streamlining Operations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 21 2024
0mins
Should l Buy ?
Source: Benzinga
- Financial Results for Q3 FY 2024: Body and Mind Inc. announced financial results for the third quarter of fiscal year 2024, showing revenue, gross profit, net operating loss, and net loss figures.
- Operational Updates: The company is focusing on streamlining operations, with growth in its Markham-based dispensary in Illinois and progress in the Lynwood store construction project.
- Expansion in New Jersey: Body and Mind received a license for a new dispensary in New Jersey, highlighting plans for a 4,000 square feet retail location in Lawrenceville.
- Market Outlook: CEO Michael Mills believes that the Illinois and New Jersey markets are underserved, expressing confidence in the company's locations and capabilities for high returns.
- Upcoming Conference: The company invites individuals interested in cannabis stocks to attend the Benzinga Cannabis Capital Conference in Chicago on Oct. 8-9 for insights into the industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
